Fulgent Genetics, Inc.
FLGT
$20.31
-$0.21-1.02%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -11.53M | -5.89M | -14.65M | -8.71M | -13.46M |
| Total Depreciation and Amortization | 5.92M | 6.19M | 5.92M | 6.15M | 6.66M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 10.97M | 8.53M | 18.97M | 9.43M | 9.16M |
| Change in Net Operating Assets | -9.79M | 16.19M | -25.75M | -2.58M | 4.91M |
| Cash from Operations | -4.43M | 25.02M | -15.51M | 4.29M | 7.27M |
| Capital Expenditure | -4.72M | -3.78M | -19.54M | -12.94M | -4.06M |
| Sale of Property, Plant, and Equipment | 2.00K | 0.00 | 38.00K | 17.00K | 258.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 32.45M | -23.68M | 28.48M | 20.23M | -43.39M |
| Cash from Investing | 27.73M | -27.46M | 8.99M | 7.30M | -47.19M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -606.00K | -136.00K | -136.00K | -602.00K | -900.00K |
| Issuance of Common Stock | -- | 51.00K | -- | -- | -- |
| Repurchase of Common Stock | -10.57M | -242.00K | -431.00K | -544.00K | -1.91M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -11.17M | -327.00K | -567.00K | -1.15M | -2.81M |
| Foreign Exchange rate Adjustments | 11.00K | -134.00K | 157.00K | -9.00K | -69.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 12.14M | -2.90M | -6.93M | 10.43M | -42.80M |